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Summary
Objective: To describe the salient epidemiologic, clinical, histopathologic, and bacteriologic
aspects of cutaneous tuberculosis in Morocco.
Methods: A retrospective review of all cases of cutaneous tuberculosis at our hospital from
January 1981 through December 2004.
Results: Two-hundred and sixteen cases of cutaneous tuberculosis were identified and included.
Men and women were equally affected. The mean patient age was 29 years. Major clinical types of
cutaneous tuberculosis were scrofuloderma and gumma (72%), lupus vulgaris (12%), tuberculosis
verrucosa cutis (7%), tuberculids (6%), orificial tuberculosis (1%), and tuberculous chancre (1%).
Systemic involvement was seen in 35%. Where performed (66%), 81% of subjects had positive
Mantoux skin tests. Lesion biopsy for histopathologic study was performed in 81% of patients and
showed classical tuberculous findings in 57%. Mycobacterium tuberculosis was isolated in culture
from 9% of patients.
Conclusion: Cutaneous tuberculosis is still a common disease in Morocco, and scrofuloderma and
gumma are the most common clinical presentations.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Tuberculosis is still a common disease in both developing and
developed countries. In many industrialized nations, the
number of reported cases of tuberculosis has increased in
recent years. Relevant factors contributing to this trend
include HIV co-infection, multidrug-resistance, immigrants
and refugees from countries of higher prevalence, and the
neglect of preventive measures.1—3 In Morocco, tuberculosis
remains endemic with 30 000 new cases reported annually.4* Corresponding author. Tel.: +212 61 40 60 98;
fax: +212 22 27 30 76.
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doi:10.1016/j.ijid.2006.02.009Cutaneous tuberculosis is a rare form of extrapulmonary
tuberculosis. In Morocco, cutaneous tuberculosis ranks fifth in
frequency after pleural, lymph node, urogenital, and intest-
inal tuberculosis. Problems in the diagnosis of cutaneous
tuberculosis are frequent because the clinical picture can
be so varied and the incidence of positive cultures is low. In
this paper we describe the clinical, histopathologic, and bac-
teriologic findings in 216 subjectswith cutaneous tuberculosis.Patients and methods
All cases of cutaneous tuberculosis seen in the Dermatology
Department of Ibn Rochd Hospital Center in Casablanca,
Morocco, from January 1981 through December 2004 werePublished by Elsevier Ltd. All rights reserved.
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Figure 3 Lupus vulgaris of the upper limb.
Figure 1 Annual incidence of cutaneous tuberculosis.
Table 1 Distribution of types of cutaneous tuberculosis
Type Number of cases Percent
Scrofuloderma and gumma 155 72
Lupus vulgaris 26 12
Tuberculosis verrucosa cutis 16 7included in this study. Data collected included age, sex,
clinical features, results of histopathology, bacteriology,
tuberculin skin testing, and chest X-ray, drug regimens used,
and treatment side effects. In some patients other investiga-
tions, where indicated, included bone radiography, lymph
node biopsy, and culture of gastric aspirates. A diagnosis of
cutaneous tuberculosis was based upon a combination of
clinical, histopathologic, and laboratory features as well as
response to antituberculous therapy.
Results
Of 11 073 patients hospitalized in our department during the
study period, 216 cases of cutaneous tuberculosis were
identified. Cases of cutaneous tuberculosis represented 2%
of all cases of skin diseases seen. The annual incidences are
shown in Figure 1. Patient ages ranged from 4 to 90 years,
with a mean of 29 years. Sixty percent of subjects were under
30 years of age. Themale:female ratio was 1.03. Five percent
of patients had a past history of tuberculosis and 27% had a
family history of tuberculosis. The skin lesion duration prior
to diagnosis ranged from 1 month to 12 years. The distribu-
tion of the various types of cutaneous tuberculosis (Figures 2
and 3) is shown in Table 1. Concomitant systemic organ
involvement was seen in 35% of cases (Table 2). Skin test,
skin biopsy, and tuberculous culture findings are summarized
in Table 3. Only a minority of our patients were tested for HIV
and all were seronegative.
Antituberculous treatment generally consisted of a 12-
month regimen of isoniazid plus streptomycin, with the addi-
tion of ethambutol during the period from 1981 to 1985. Nine-Figure 2 Scrofuloderma in the inguinal area.and 6-month regimens consisting of isoniazid and rifampin
(supplemented by pyrazinamide for the initial two months)
were used during the periods 1986 through 1989 and from 1999
onwards, respectively. Ninety-three percent of patients
responded favorably to antituberculous treatment, while 7%
had complications that included drug-induced hepatitis (three
cases), deafness (two cases), and disease relapse (two cases).Tuberculids 13 6
Orificial tuberculosis 3 1
Tuberculous chancre 3 1
Total 216 100
Table 2 Systemic organ involvement in 216 patients with
cutaneous tuberculosis
Site Number of patients Percent
Lungs 26 12
Bones 24 11
Lymph nodes 17 8
Soft tissues abscess 6 3
Disseminated disease 2 1
Total 75 35
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Table 3 Skin test, skin biopsy, and culture findings in 216
patients with cutaneous tuberculosis
Test Performed (%) Positive (%)
Mantoux reactivity 66 81
Histopathology 81 57a
Culture 56 9
a Epithelioid granulomata  caseation.Discussion
Cutaneous tuberculosis is still a common disease in Morocco
despite BCG vaccination at birth, and represents 2% of all the
dermatologic conditions seen in our hospital. Cutaneous
tuberculosis accounts for <0.5% of all skin diseases in Eur-
ope,5,6 and between 0.1% and 0.5% of skin conditions in
India.7—9 Tuberculosis of the skin is most commonly seen in
young adults;9,10 in our study 60% of patients were under 30
years of age. We did not observe the male predominance
noted in previous studies.5,11
The clinical diversity of cutaneous tuberculosis depends
on the route of acquisition of infection and on the patient’s
immune status. In relation to host immunity, cutaneous
tuberculosis represents a continuous spectrum with lupus
vulgaris (high degree of immunity) at one extreme, scroful-
oderma and tuberculous gumma (low degree of immunity) at
the other, and tuberculosis verrucosa cutis occupying an
intermediate position.6,12 Scrofuloderma results from con-
tiguous involvement of the skin from underlying tuberculosis
in deeper structures such as lymph nodes, bone, or epididy-
mis. Tuberculous gumma are the result of hematogenous
dissemination from a primary non-cutaneous focus. Our
patients displayed scrofuloderma and gumma as the fre-
quently encountered types of cutaneous tuberculosis, in
contrast to other Maghrebian series where lupus vulgaris
has beenmore commonly seen.10,13 This difference in disease
distribution probably reflects a higher socioeconomic status
in these countries. Lupus vulgaris usually results from rein-
fection of the skin; or it may develop from direct extension or
hematogenous or lymphatic spread from visceral tuberculo-
sis.14 Rarely, it can appear on the site of BCG vaccination.15,16
In Europe and the USA, lupus vulgaris is rare but still presents
as the most common type of cutaneous tuberculosis seen,6,14
as it is in India and South Africa as well.10,17 In Hong Kong,
recent reviews suggest a shift in the highest frequency of
cutaneous tuberculosis from tuberculosis verrucosa cutis18 to
tuberculids and lupus vulgaris.19
In our series no case of HIV infection was found, likely
reflecting the low incidence of HIV infection in Morocco.
Atypical dermatologic presentations of the disease and mili-
ary dissemination to the skin have been reported in HIV-co-
infected individuals.5,20,21
Concomitant extracutaneous tuberculosis has been
reported in 5% to 21% of patients with cutaneous tubercu-
losis.19,22 We found a substantially higher percentage of
active extracutaneous disease in our patients, which may
be explained by the predominance of scrofuloderma and
gumma in our series.
The optimal diagnosis of cutaneous tuberculosis relies on
the demonstration of acid-fast bacilli in skin lesions, althoughculture provides only a small diagnostic yield in patients with
cutaneous tuberculosis,11,23 as noted in our series. The diag-
nosis is typically made presumptively based on the correla-
tion of various criteria including the presence of active
tuberculosis elsewhere, histopathologic findings, clinical his-
tory and physical signs, a positive purified protein derivative
(PPD) skin test reaction, and a therapeutic response to
antituberculous treatment. Automated culture systems such
as the Bactec1 provide rapid and sensitive results but are
expensive.24 Several case reports indicate the usefulness of
polymerase chain reaction (PCR) in the diagnosis of scroful-
oderma, lupus vulgaris, and tuberculids.25,26
The majority of our patients responded satisfactorily
to antituberculous therapy. In Morocco the current national
first-line drug regimen for pulmonary and extrapulmonary
tuberculosis consists of isoniazid, rifampin, and pyrazina-
mide administered for the first two months, followed
by isoniazid plus rifampin given for an additional four
months.
In conclusion, cutaneous tuberculosis is still a common
disease in Morocco. Scrofuloderma, gumma, and lupus vul-
garis are the most common clinical types encountered and
reflect the developing nation status of our country.
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